Who shouldnt take tirzepatide Tirzepatide isnt right for everyone, especially if you have certain health conditions that could raise the risk of complications
Last year, the SELECT trial demonstrated that use of Wegovy significantly reduced the risk for first occurrence of adverse cardiovascular events, including heart attacks and strokes in study participants
As virtual care brands expand, reaching the right patients and healthcare professionals while communicating safely and effectively
In 2015, the SCALE Obesity and Prediabetes study group found that two-thirds of participants lost at least 5% of their body weight while taking liraglutide, and one-third lost at least 10%
In another 2025 study by Qeadan and colleagues that used electronic health data from over 1.3 million individuals with a history of alcohol use disorder and opioid use disorder, researchers found that individuals with alcohol use disorder (n=817,309) prescribed GLP-1 medications experienced about 50% fewer alcohol intoxication events over the 2-year period compared to patients who didnt receive the medications (Qeadan et al., 2025)
At the same time, there has been a rise in the use of a medication called semaglutide
